Clinical Highlights
Fluoroless Left Atrial Access for Radiofrequency and Cryoballoon Ablations Using a Novel Radiofrequency Transseptal Wire
Authors: Study led by Dr. Hany Demo
†Using the exchangeless VersaCross® RF Transseptal Solution. Demo et al., Journal of Interventional Cardiac Electrophysiology (JICE), Feb 2022 DOI: 10.1007/s10840-022-01157-5
Initial Clinical Experience with VersaCross™ Transseptal System for Transcatheter Mitral Valve Repair
Authors: Study led by Dr. Anita Asgar
†Using the VersaCross™ RF Transseptal Solution from femoral access; based on 3.3 min for TSP and 3.8 min for subsequent MitraClip guide exchange. Maisano, et al. DOI: 10.1002/ccd.29365
Safety and Effectiveness of a Novel Fluoroless Transseptal Puncture Technique for Lead-free Catheter Ablation: A Case Series
Authors: Study led by Dr. Tariq Salam
EAM images from Salam et al. 2020, DOI: 10.19102/icrm.2020.110405, used under CC BY license, granted by Journal of Innovations in Cardiac Rhythm Management
VersaCross™ Radiofrequency System Reduces Time to Left Atrial Access versus Conventional Mechanical Needle
Authors: Study led by Dr. Jacqueline Saw
†compared to 13.4 mins using BRK needle in a retrospective comparison, VersaCross™ RF Transseptal Solution delivered LAAC sheath in 6.7 mins, Inohara et al. J Interv Card Electrophys, 2021 DOI: 10.1007/s10840-020-00931-7
